<DOC>
	<DOCNO>NCT01089569</DOCNO>
	<brief_summary>The primary purpose study compare effect 24-hour blood glucose pattern , HbA1c , weight management add insulin glargine , exenatide , combination insulin glargine exenatide metformin .</brief_summary>
	<brief_title>Continuous Glucose Monitoring Evaluation Exenatide Twice Daily Versus Insulin Glargine</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Male female subject ≥18 ≤75 year age Clinical diagnosis type 2 diabetes Diabetes duration ≥ 1 year HbA1c ≥7.0 % Currently treat metformin ( HbA1c ≤9 % ) metformin/sulfonylurea ( SU ) ( HbA1c ≤8 % ) SU alone ( HbA1c ≤8 % ) Previously treat insulin incretinbased therapy Treated thiazolidinedione within past 6 week Taken oral inject prednisone cortisone medication previous 30 day Any pancreatic disease high risk pancreatitis ( history alcohol abuse , active gallbladder disease ) Serum creatinine &gt; 1.4mg/dL ( woman ) &gt; 1.5 mg/dL ( men ) eGFR &lt; 30 ml/min ( use MDRD equation ALT &gt; 2xULN Presence severe medical psychological condition chronic conditions/infections opinion Investigator would compromise subject 's safety successful participation study Currently pregnant plan pregnancy study period Unable follow study protocol Unable speak , read write English Uncontrolled hyperglycemia HbA1c &gt; 9 % metformin &gt; 8 % SU metformin/SU combination ketonuria require immediate insulin therapy At investigator 's discretion medical psychological reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>diabetes</keyword>
	<keyword>continuous glucose monitoring</keyword>
	<keyword>exenatide</keyword>
	<keyword>insulin glargine</keyword>
</DOC>